4 ms·
so it would be better for orzempic to cost $850,000 and limit its indication to people with MODY? How is that realistic? TBH I have way less a problem with ph
by DarkmSparks 3y ago
so it would be better for orzempic to cost $850,000 and limit its indication to people with MODY?
How is that realistic?
TBH I have way less a problem with pharma industry being allowed to make profits than health insurance companies. In fact the US is about the only country in the world that allows profits from health insurance.
- Ekaros 3y agoI don't see health insurance making profit being unreasonable. That is key reason why anyone would run an insurance scheme. Now the USA model is entirely wrong. But fundamentally, to offer insurance you must get something out of it.
- DarkmSparks 3y agohealth insurance profit is forgone health. every other country only allows them to exist as not-for-profits. whereas expensive medicines just make health insurance less profitable. This is the basic principle behind why the US spends the most in the world on healthcare to achieve among the worst outcomes (e.g. same life expectancy as most undeveloped 3rd world countries)
- TylerE 3y agoThe target market for Ozempic is tens of millions of people taking it every week. The blindness thing has a worldwide demand cap of about 40 doses per year - it's a single dose for life in each eye). Are you equally surprised when a one-off bespoke PCB costs more than a stock RaspPi?
- DarkmSparks 3y agoThe point was the profit margin on both the blindness drug and AMD CPUs are significantly higher than for ozempic. So why target ozempic for too high a profit margin? Caveated with its the health insurance industry is paying that profit margin - not the people who _should_ be taking it.